Share
Andre-Jacques Auberton-Herve
FineHeart S.A., a clinical-stage medtech company specializing in innovative cardiology solutions, has announced the appointment of André-Jacques Auberton-Hervé to its Board of Directors.
This appointment represents a significant milestone in FineHeart's growth as it advances its clinical program in Europe and prepares for global expansion.
Auberton-Hervé brings extensive expertise in driving disruptive technologies to commercial success. As the co-founder and former Chairman of SOITEC, he led the company to global leadership in semiconductors over 23 years, transforming it into an international high-tech group with a valuation exceeding US$5 billion.
His experience includes serving as a member of the European Commission's Key Enabling Technologies group and holding leadership roles in the semiconductor industry, including a tenure as Chairman of SEMI. He is also actively involved in guiding innovative companies in fields like digital imaging, MicroLED displays, and neuroscience.
Auberton-Hervé’s addition to FineHeart’s Board is expected to provide strategic insights and support as the company scales up its operations and continues developing its flagship technology, the FlowMaker, designed to address advanced heart failure.
